Literature DB >> 23730843

Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.

A Khedive1, M Norouzi, F Ramezani, H Karimzadeh, S M Alavian, R Malekzadeh, G Montazeri, A Nejatizadeh, M Ziaee, F Abedi, B Ataei, M Yaran, B Sayad, M H Somi, G Sarizadeh, I Sanei-Moghaddam, F Mansour-Ghanaei, H Rafatpanah, M A Pourhosseingholi, H Keyvani, E Kalantari, M Saberifiroozi, M A Judaki, S Ghamari, M Daram, M Mahabadi, Z Fazeli, Z Goodarzi, V Poortahmasebi, S M Jazayeri.   

Abstract

Mutations within the coding region of hepatitis B surface antigen (HBsAg) have been found naturally in chronic carriers. To characterize the mutations of HBsAg from Iranian chronic carriers who were vaccine and/or medication naive. The surface genes from 360 patients were amplified and directly sequenced. The distribution of amino acid substitutions was classified according to different immune epitopes of the surface protein. All isolates belonged to genotype D. 222 (61.6%) of 360 patients contained at least one amino acid substitution. 404 (74.5%) of 542 amino acid changes occurred in different immune epitopes of HBsAg, of which 112 (27.7%) in 32 residues of B-cell epitopes (62 in the 'a' determinant); 111 (27.4%) in 32 residues of T helper; and 197 (48.7%) in 32 residues inside cytotoxic T lymphocyte (CTL) epitopes. One Th (186-197) and two CTL (28-51 and 206-215) epitopes were found to be hotspot motifs for the occurrence of 213 (52.7%) substitutions. 20 stop codons were identified in different epitopes. There was a significant association between amino acid substitutions and anti-HBe seropositivity; however, the correlation between such changes with viral load and ALT levels was not significant. In chronic hepatitis B virus(HBV) carriers, positive selection in particular outside the 'a' determinant appeared to exert influence on the surface proteins. These changes could be immune escape mutations naturally occurring due to the host immune surveillance especially at the T-cell level.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23730843     DOI: 10.1111/jvh.12045

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  12 in total

1.  A new vaccine escape mutant of hepatitis B virus causes occult infection.

Authors:  Qing Ye; Shi-Qiang Shang; Wei Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces.

Authors:  Fatemeh Ramezani; Seyed Moayed Alavian; Ahmadreza Sadeghi; Abolfazl Khedive; Leila Ghalichi; Mehdi Norouzi; Hadi Karimzadeh; Reza Malekzadeh; Ghodrat Montazeri; Azim Nejatizadeh; Masood Ziaee; Farshid Abedi; Behrooz Ataei; Majid Yaran; Babak Sayad; Mohamad Hosein Somi; Gholamreza Sarizadeh; Ismail Sanei-Moghaddam; Fariborz Mansour-Ghanaei; Houshang Rafatpanah; Hossein Keyvani; Ebrahim Kalantari; Mehdi Saberfiroozi; Reza Rezaee; Maryam Daram; Mostafa Mahabadi; Zahra Goodarzi; Vahdat Poortahmasebi; Babak Geravand; Azam Khamseh; Masoud Mahmoodi; Seyed Mohammad Jazayeri
Journal:  Iran J Microbiol       Date:  2015-08

4.  Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features.

Authors:  Vahdat Poortahmasebi; Reza Malekzadeh; Ghodratollah Montazeri; Ehsan Fakhari; Mehdi Norouzi; Azam Khamseh; Masoud Mahmoodi Karkhaneh; Ahmad Tavakoli; Seyed Mohammad Jazayeri
Journal:  Jundishapur J Microbiol       Date:  2015-09-12       Impact factor: 0.747

5.  Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant.

Authors:  Yuan Xue; Ming-Jie Wang; Zhi-Tao Yang; De-Min Yu; Yue Han; Dao Huang; Dong-Hua Zhang; Xin-Xin Zhang
Journal:  Emerg Microbes Infect       Date:  2017-03-22       Impact factor: 7.163

Review 6.  Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen.

Authors:  Sheila F Lumley; Anna L McNaughton; Paul Klenerman; Katrina A Lythgoe; Philippa C Matthews
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

7.  Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients.

Authors:  Narjes Shokatpour; Maryam Vaezjalali; Graham R Foster; Shahnaz Sali
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

8.  Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma.

Authors:  Vahdat Poortahmasebi; Ahmad Nejati; Mohammad Foad Abazari; Mohsen Nasiri Toosi; Azam Ghaziasadi; Nader Mohammadzadeh; Ahmad Tavakoli; Azam Khamseh; Navid Momenifar; Omid Gholizadeh; Mehdi Norouzi; Seyed Mohammad Jazayeri
Journal:  Can J Gastroenterol Hepatol       Date:  2022-02-28

9.  Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.

Authors:  Said Ali Al Baqlani; Bui Tien Sy; Boris A Ratsch; Khalid Al Naamani; Salah Al Awaidy; Suleiman Al Busaidy; Georg Pauli; C-Thomas Bock
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  Appropriate Genotyping of Hepatitis B Virus in Iran.

Authors:  Seyed Mohammad Jazayeri; Heidar Sharafi; Seyed Moayed Alavian
Journal:  Jundishapur J Microbiol       Date:  2015-10-17       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.